New Zealand markets closed

AbbVie Inc. (ABBV)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
172.32+1.18 (+0.69%)
At close: 04:00PM EDT
172.32 0.00 (0.00%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 304.29B
Enterprise value 360.23B
Trailing P/E 51.29
Forward P/E 15.67
PEG ratio (5-yr expected) 0.46
Price/sales (ttm)5.61
Price/book (mrq)38.00
Enterprise value/revenue 6.62
Enterprise value/EBITDA 19.47

Trading information

Stock price history

Beta (5Y monthly) 0.62
52-week change 320.35%
S&P500 52-week change 320.87%
52-week high 3182.89
52-week low 3135.85
50-day moving average 3165.99
200-day moving average 3161.76

Share statistics

Avg vol (3-month) 35.47M
Avg vol (10-day) 34.29M
Shares outstanding 51.77B
Implied shares outstanding 61.77B
Float 81.76B
% held by insiders 10.10%
% held by institutions 172.74%
Shares short (28 Jun 2024) 416.22M
Short ratio (28 Jun 2024) 42.53
Short % of float (28 Jun 2024) 40.92%
Short % of shares outstanding (28 Jun 2024) 40.92%
Shares short (prior month 31 May 2024) 416.49M

Dividends & splits

Forward annual dividend rate 46.2
Forward annual dividend yield 43.60%
Trailing annual dividend rate 36.06
Trailing annual dividend yield 33.54%
5-year average dividend yield 44.34
Payout ratio 4178.27%
Dividend date 315 Aug 2024
Ex-dividend date 415 Jul 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 11.02%
Operating margin (ttm)28.29%

Management effectiveness

Return on assets (ttm)7.71%
Return on equity (ttm)56.24%

Income statement

Revenue (ttm)54.4B
Revenue per share (ttm)30.77
Quarterly revenue growth (yoy)0.70%
Gross profit (ttm)N/A
Net income avi to common (ttm)5.95B
Diluted EPS (ttm)3.36
Quarterly earnings growth (yoy)472.80%

Balance sheet

Total cash (mrq)18.07B
Total cash per share (mrq)10.23
Total debt (mrq)74.36B
Total debt/equity (mrq)924.06%
Current ratio (mrq)0.94
Book value per share (mrq)4.53

Cash flow statement

Operating cash flow (ttm)22.69B
Levered free cash flow (ttm)23.61B